Scientific Advisory Board

Syngulon, a synthetic biology startup, announced its Scientific Advisory Board (SAB) comprised of leading academic and industrial experts in microbiology with experience in both Europe and the USA. In 2016, the USPTO issued US Patent 9,333,227 to Syngulon for the use of bacteriocin/immunity in any bacteria, yeast or algae for controlled growth of microorganisms. The …

Biofit Strasbourg

Guy Helin, CEO Syngulon, is chairman of a session today at Biofit in Strasbourg, France about “Networks and alliances with the industry: how can TTOs contribute to their success?”. BioFIT is the leading partnering event in Europe for Open Innovation, technology transfer and collaborative research in the field of Life Sciences, with the highest attending …

EFIB 2015

Dr Philippe Gabant, Founder & CSO of Syngulon, will be speaker on 28 October in Brussels at EFIB 2015 in the Innovation Track 1 – SME innovation showcase. EFIB, The European Forum for Industrial Biotechnology and the Bioeconomy, is THE market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy.

Canada for Americana

Syngulon is in Montreal, Canada for Americana (March 17 to 19). On Wednesday March 18, Syngulon will make a presentation in the Innovation Corner as member of the Belgian delegation. Americana, the International Environmental Technology Trade Show and Conference, is recognized as one of the leading multi-sector events of its kind in North America. It …

The alliance of green chemistry and white biotechnology

Biorem Engineering and Syngulon sign a strategic partnership: The alliance of green chemistry and white biotechnology Biorem Engineering and Syngulon announced the conclusion of a strategic partnership for development of truly novel products and services combining their technologies and know-how in green chemistry and white biotechnology. The pooling of their respective competences will improve the …